Clemens Warnke

Has grant

University Hospital Bonn

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Progressive multifocal leukoencephalopathy: biomarkers for early diagnosis, risk assessment of immunotherapies, and response to targeted therapy

Open Date: 2022-01-01

Close Date:

Grant: Close

Immune-mediated pathogenesis and development of autoimmunity in neurological manifestations of COVID-19

Open Date: 2021-01-01

Close Date: 2022-12-31

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Refik Pul

Prof. Dr. med

university medicine essen

GERMANY

View details

Stefan Bittner

Johannes Gutenberg Universität Mainz

GERMANY

View details

Carolin Schwake

Ruhr-Universität Bochum

GERMANY

View details

Friedemann Paul

GERMANY

View details

Kerstin Hellwig

Ruhr-Universität Bochum

GERMANY

View details

Ilijas Jelcic

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Clemens Warnke

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review

Analysis of Cerebral CT Based on Supervised Machine Learning as a Predictor of Outcome After Out-of-Hospital Cardiac Arrest

Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serum

Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry

“So at least now I know how to deal with things myself, what I can do if it gets really bad again”—experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study

Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome

Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy

Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy

Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases COPANMO(G)-Study

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome

Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptoms

Development of a Long-Term Cross-Sectoral Case and Care Management Manual for Patients With Severe Multiple Sclerosis and Their Caregivers

Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors

Collaborators (6)

Refik Pul

Stefan Bittner

Carolin Schwake

Friedemann Paul

Kerstin Hellwig

Ilijas Jelcic

Make your next move.